How well are biologic and conventional DMARDs tolerated in psoriatic arthritis: A real world study

Objective: Even though disease-modifying antirheumatic drugs (DMARDs) are well established in routine clinical practice, longitudinal real-world data for their retention and tolerability are sparse, especially in psoriatic arthritis (PsA) patients. Our objective was to describe the characteristics o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jawad, Issrah I., Nisar, Muhammed K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Research and Education Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176215/
https://www.ncbi.nlm.nih.gov/pubmed/35156631
http://dx.doi.org/10.5152/eurjrheum.2021.21027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176215/
https://www.ncbi.nlm.nih.gov/pubmed/35156631
http://dx.doi.org/10.5152/eurjrheum.2021.21027

Ejemplares similares